FDA Investigator Jose R Lopez

Jose R Lopez has inspections in 5 countries as of 20 Sep 2023. Jose R Lopez has collaborated with a combined 3576 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
20 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, United Kingdom of Great Britain and Northern Ireland, Poland, Ireland
Adalberto Cajigas, Adaliz Santaliz Cruz, Agnes M Santori, Alan A Rivera, Alicia M Mozzachio, An T Vu, Anastasia M Shields, Andrea George, PhD, Angelica M Hernandez, Ann L Demarco, Annette Melendez, Ariel Cruz Figueroa, Arlene M Badillo, Ashley N Queen, PhD, Brenda Rivera, Brian J Ryan, Calvin B Koerner, Carlos A Medina, Carlos Arivera Ramirez, Cassandra L Abellard, CDR Ileana Barreto Pettit, Charisse K Green, Chelsea N Sealey, Cheryl A Clausen, Christopher Downey, PhD, Colleen F Hoyt, Colleen Thomas, PhD, Dayna I Martinez, Debra I Love, Dennis Cantellops Paite, Devaughn Edwards, Dewayne E Whitlock, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Dorota Matecka, PhD, Douglas A Campbell, Dov Pluznik, PhD, Dr. Carmelo Rosa, Edwin Martinez, Eliezar Ramos, Erika V Butler, Eva I Merced Medina, Eva Merced, Evaj Mored, Frances L Dejesus, Frederick L Fricke, George J Flynn, German Rivera, Hector Espinet, Hector J Colon Torres, Ileana Pettit, Iraida Ortiz, Ivis L Negron, Ivis Lnegron Torres, Ivonne A Vicente, Jaime E Pares, Javier O Vega, Jennifer A Quinones, Jennifer Lalama, Jerri Baker, Joan Cantellops Figueroa, Joan M Cantellops Figueroa, Joe X Phillips, Jorge E Martinez, Jorge L Guadalupe, Jorge L Lajara, Jose A Cruz, Jose A Lopez, Jose A Moreno, Jose Acruz Gonzalez, Jose Alopez Rubet, José E Meléndez, Jose E Melendez, DDC, Jose Fpedrode Jesus, Jose M Cayuela, Jose Martinez, Jr, Jose Melendez, José Meléndez, Jose Perez Soto, Jose Rflores Veguilla, Jose Rflores Vequilla, Jose Velez, Juan Rjimenez Garcia, Karl D Hezel, Kathryn E Ogger, Laiza V Garcia, Laura E Garcia, Laurimer Kuilan, Laurimer Kuilan Torres, Libia M Lugo, Lisa M Lopez, Lizaida E Rodriguez, Loreily Figueroa, Loreily Figueroa Agrinsoni, Lourdes Andujar, LT Luis O Rodriguez, LT Rafael Gonzalez, Luis A Carrion, Margarita Santiago, Maria Gutierrez Lugo, PhD, Marian E Ramirez, Marianela Aponte, Marianela Aponte Cruz, Maribel V Juarbe, Marie T Falcone, Marilyn Santiago, Marisal Faberhe, Marisol Faberlle, Mark R Mcclain, Marlene Rodriguez Colon, Marta E Gonzalez, Maxwell Van Tassell, PhD, Medina, Michael A Charles, Michael E Maselli, Michael Levy, Michael R Klapal, Michael Shanks, MS, Michelle Y Clark Stuart, Miguel A Martinez, Miguel G Manzano, Mihaly S Ligmond, Milva E Melendez, Milva Emelendez Perales, Min Tang, Minerva Rogers, Mra Davism, Muralidhara B Gavini, PhD, Myriam M Sosa, Nancy Rosado, Nicholas Obiri, PhD, Nikolay Spiridonov, Noreen Muniz, Noreen Muñiz, Nydia E Colon, Omotunde O Osunsanmi, Pablo Feliciano, Parul M Patel, Patricia Fhughes Troost, Patrick C Klotzbuecher, Paul A Bonneau, Paul Z Balcer, Paula A Trost, Philip F Istafanos, DMV, MS, Rafael E Arroyo, Rafael E Cruz, Rafael Nevarez, Rafael Nevarez Nieves, Ramesh Potla, PhD, Ramon A Hernandez, Raquel Gonzalez Rivera, Rebeca M Melendez, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Riley C Myers, PhD, Robert D Tollefsen, Robert Darius, Russell J Glapion, Ruth Moore, PhD, Sandra Carpio, Sangeeta M Khurana, PhD, Sarah E Mcmullen, Shirley J Berryman, Simone E Pitts, Sixto M Mercado, Sixto M Mercado Rios, Sixto Mercado Rios, Sonia M Monges, Stacie A Woods, State Agency, Stephanie D Crockett, Steven B Barber, Steven C Madzo, Steven Fong, MS, PhD, Steven M Weinman, Steven P Donald, Susan P Bruederle, Susanna E Ford, Analyst, Tajah L Blackburn, Thao T Kwan, Thomas J Arista, Tiara Nbrown Crosen, Timothy Wadkin, PhD, Victor S Pacheco, Vilmary Negron Rodriguez, Walden H Lee, Wanda J Torres, Wendy G Tan, PhD, Zachary L Stamm, Zhihao Qiu (Peter), PhD, Zhong Li, PhD, Zhongren Wu

Jose R Lopez's Documents

Publish Date Document Type Title
October, 2012 FDA 483 Caribe Holdings (Cayman) Co. Ltd. dba PuraCap Caribe - Form 483, 2012-10-22
June, 2012 EIR Boehringer Ingelheim Animal Health Puerto Rico LLC - EIR, 2012-06-20
November, 2010 FDA 483 McNeil Healthcare LLC. - Form 483, 2010-11-02
April, 2013 FDA 483 Auro PR Inc. - Form 483, 2013-04-24
April, 2012 FDA 483 VWR Advanced Instruments, LLC - Form 483, 2012-04-03
June, 2012 FDA 483 Boehringer Ingelheim Animal Health Puerto Rico LLC - Form 483, 2012-06-20
August, 2010 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2010-08-13
September, 2012 FDA 483 TAPI Puerto Rico, Inc. - Form 483, 2012-09-18
March, 2014 FDA 483 Pfizer Pharmaceuticals LLC - Form 483, 2014-03-11
November, 2010 FDA 483 McNeil Healthcare, LLC - Form 483, 2010-11-02
May, 2010 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2010-05-04
March, 2013 FDA 483 NEOLPHARMA, INC. - Form 483, 2013-03-07
August, 2011 FDA 483 Brisas del Caribe Corp. - Form 483, 2011-08-12
October, 2012 EIR Caribe Holdings (Cayman) Co. Ltd. dba PuraCap Caribe - EIR, 2012-10-22
May, 2009 FDA 483 Janssen Ortho LLC - Form 483, 2009-05-11
November, 2014 EIR Wyeth Pharmaceuticals Company - EIR, 2014-11-17
July, 2013 EIR IPR Pharmaceuticals, Inc - EIR, 2013-07-29
March, 2010 FDA 483 Dentsply Prosthetics - Form 483, 2010-03-18
October, 2011 FDA 483 McNeil Healthcare LLC. - Form 483, 2011-10-26
January, 2010 FDA 483 McNeil Healthcare LLC. - Form 483, 2010-01-08
November, 2014 FDA 483 Wyeth Pharmaceuticals Company - Form 483, 2014-11-17
April, 2012 EIR VWR Advanced Instruments, LLC - EIR, 2012-04-03
April, 2013 EIR Auro PR Inc. - EIR, 2013-04-24
January, 2010 FDA 483 Response McNeil Healthcare LLC. - Form 483R, 2010-02-05
March, 2014 EIR Viatris Pharmaceuticals LLC - EIR, 2014-03-11
September, 2011 FDA 483 Gasco Industrial - Form 483, 2011-09-21
June, 2011 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2011-06-15
April, 2011 EIR Amgen Manufacturing Ltd - EIR, 2011-04-29
June, 2012 EIR TAPI Puerto Rico, Inc. - EIR, 2012-06-29
January, 2009 FDA 483 Galephar Pharmaceutical Research Inc - Form 483, 2009-01-30
March, 2014 FDA 483 Viatris Pharmaceuticals LLC - Form 483, 2014-03-11
April, 2011 FDA 483 Amgen Manufacturing Ltd - Form 483, 2011-04-29
March, 2014 FDA 483 Ex-Lax, Inc. - Form 483, 2014-03-05
June, 2012 FDA 483 TAPI Puerto Rico, Inc. - Form 483, 2012-06-29
July, 2013 FDA 483 IPR Pharmaceuticals, Inc - Form 483, 2013-07-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more